23
Participants
Start Date
August 9, 2012
Primary Completion Date
November 3, 2016
Study Completion Date
November 3, 2016
Pomalidomide (CC-4047)
1 mg orally every day for 52 weeks
Placebo
Matching placebo capsules taken orally once a day
Monash Medical Centre, Clayton
University Hospital Basel, Basel
The Prince Charles Hospital, Chermside
The Queen Elizabeth Hospital, Woodville South
Charite - Universitätsmedizin Berlin, Berlin
North Shore-LIJ Health System-Division of Rheumatology, Great Neck
University of Pittsburgh, Pittsburgh
Complejo Hospitalario de Santiago, Santiago de Compostela
Azienda Ospedaliera Universitaria S. Martino di Genova, Genova
University of Pennsylvania, Philadelphia
Delaware Medical Care Associates, LLC, Newark
Georgetown University School of Medicine, Washington D.C.
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan
Ospedale Luigi Sacco, Milan
IRCCS Policlinico S. Matteo di Pavia, Pavia
Hospital Universitario Gregorio Maranon, Madrid
Hospital Universitario 12 de Octubre, Madrid
Arthritis Research and Treatment Center, Stockbridge
USF Health Faculty Office Building-FOB, Tampa
University of Toledo College of Medicine, Toledo
Cleveland Clinic, Cleveland
Rheumazentrum Ruhrgebiet, Herne
Hospital Universitario Dr. Peset, Valencia
LaPorte County Institute for Clinical Research, Inc, Michigan City
University of Michigan, Ann Arbor
Medical College of Wisconsin, Milwaukee
Azienda Ospedaliera Universitaria Pisana, Pisa
CHRU de Lille FR, Lille
Klinikum der J.W. Gothe-Universitat Frankfurt, Frankfurt
University of Illinois at Chicago, Chicago
Kerckhoff-Klinik gGmbH, Bad Nauheim
Louisiana State University, Shreveport
Hopital Saint Louis, Paris
Groupe Hospitalier Saint Vincent de Paul, Paris
University of Texas Health Science Center at Houston, Houston
University Hospital of Ulm, Ulm
UCLA Division of Rheumatology, Los Angeles
University of Erlangen-Nuremberg, Erlangen
Advances in Medicine, Rancho Mirage
Institution of the Russian Academy of Medical Sciences Research Institute of Rheumatology of the Ru, Moscow
"St. Petersburg State Healthcare Institution Clinical Rheumatology Hospital # 25", Saint Petersburg
Penza Regional Clinical Hospital n.a. N.N. Burdenko, Penza
University of Kentucky, Lexington
Boston University of Medicine BUMC, Boston
UMDNJ-Robert Wood Johnson Medical School Clinical Research Center, New Brunswick
Policlinico Umberto I, Roma
Policlinico Universitario Agostino Gemelli, Roma
Centrum Miriada Prywatny Gabinet Specjalistyczny Profesora Dra Stanislawa Sierakowskiego, Bialystok
Szpital Uniwersytecki nr 2 im. Dr Jana Biziela w Bydgoszczy, Bydgoszcz
SPSK Nr 7 Slaskiego Uniwersytetu Medycznego, Oddzial Chorob Wewnetrznych i Reumatologii, Katowice
Samodzielny Publiczny Szpital Kliniczny nr 1 im. prof.Tadeusza Sokolowskiego Pomorskiego UM w Szczec, Szczecin
Instytut Reumatologii, Klinika i Poliklinika Ukladowych Chorób Tkanki Lacznej, Warsaw
Akademicki Szpital Kliniczny Klinika Reumatologii i Chorob Wewnetrznych, Wroclaw
Chapel Allerton Hospital, Leeds
Royal Free Hospital, London
Royal Brompton Hospital - Interstitial Lung Disease Unit, London
Lead Sponsor
Celgene
INDUSTRY